Pharmaceutical Statistics

Papers
(The H4-Index of Pharmaceutical Statistics is 13. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Generalizing Treatment Effect to a Target Population Without Individual Patient Data in a Real‐World Setting57
Prediction Intervals for Overdispersed Binomial Endpoints and Their Application to Toxicological Historical Control Data34
A Likelihood Perspective on Dose‐Finding Study Designs in Oncology25
Average Hazard as Harmonic Mean22
Estimators for handling COVID‐19‐related intercurrent events with a hypothetical strategy21
Using an early outcome as the sole source of information of interim decisions regarding treatment effect on a long‐term endpoint: The non‐Gaussian case19
Using Off‐Treatment Sequential Multiple Imputation for Binary Outcomes to Address Intercurrent Events Handled by a Treatment Policy Strategy18
Prospectively Specified Adaptive Bayesian Borrowing: Considerations, Methodologies, and Implementations17
Adaptive Constrained Weighted Estimation for Incorporating Multiple External Information Sources16
A Weighted Geometric Average Hazard Ratio Based Sample Size Formula for Non‐Proportional Hazards and Its Application to a Smoothed Piecewise Model in Cancer Immunotherapy Trial Design15
A Bayesian method for safety signal detection in ongoing blinded randomised controlled trials14
Pre‐Posterior Distributions in Drug Development and Their Properties13
Improved inference forMCP‐Modapproach using time‐to‐event endpoints with small sample sizes13
Frailty model with change points for survival analysis13
0.036622047424316